Skip to main content

Table 1 Baseline characteristics of patients

From: Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial

Characteristics

UC-MSCS (N = 45)

Placebo (N = 46)

p-value

Age (years)

50.00 ± 9.38

50.45 ± 8.03

0.8068

Gender (male) (n (%))

28 (62.22%)

30 (68.18%)

0.5552

BMI (kg/m2)

28.69 ± 3.35

28.13 ± 3.04

0.4158

Duration of diabetes (years)

11.44 ± 4.78

11.70 ± 3.96

0.7808

Insulin requirement (U/day)

57.36 + 18.90

56.41 + 12.54

0.7819

Insulin requirement (U/kg/day)

0.72 ± 0.20

0.71 ± 0.15

0.6992

Fasting plasma glucose (mmol/L)

8.71 ± 2.16

8.58 ± 1.93

0.7737

Glycated hemoglobin A1c (%)

9.02 ± 1.27

8.89 ± 1.11

0.6173

Fasting C-peptide (ng/mL)

2.01 ± 0.70

1.93 ± 0.65

0.5905

GIR (mg/min/kg)

3.12 ± 1.46

3.26 ± 1.16

0.6177

  1. Data are shown as mean ± SD or n (%). GIR, Glucose infusion rate